MERCK & CO., INC. (MRK)
Clinical trial NCT07469774 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-03-17 → 2026-03-31 3. enrollment: not set → 111 participants
NORTHWEST BIOTHERAPEUTICS INC
Clinical trial NCT06104397: enrollment: not set → 288 participants.
ABBVIE INC. (ABBV)
Clinical trial NCT06468228 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 1400 participants
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Clinical trial NCT07335601 updates: 1. completion date: 2027-12-01 → 2029-03-01 2. primary completion date: 2027-07-01 → 2028-08-01 3. enrollment: not set → 120 participants
TRAVERE THERAPEUTICS, INC. (TVTX)
Clinical trial NCT06431893 updates: 1. completion date: 2027-01-01 → 2030-08-01 2. primary completion date: 2027-01-01 → 2030-08-01 3. enrollment: not set → 100 participants
G CITY LTD (GCT)
Register of shareholders, changes and share capital status - expiration of warrants
KEYSIGHT TECHNOLOGIES, INC. (KEYS)
Keysight Tackles Semiconductor Talent Gap with Executable RF Design Whiteboard
Q2 HOLDINGS, INC. (QTWO)
Austin FC and Q2 Announce OCA Foods as the 2026 Austin FC Dream Starter Competition Winner
GLOO HOLDINGS, INC. (GLOO)
Gloo Announces 2026 AI Hackathon Focused on “Building Together: Humans, Agents and the Future of Flourishing”
CEMEX SAB DE CV (CX)
Cemex, Port Tampa Bay and Mayor Castor Complete $36M Terminal Expansion to Support Regional Growth